RET and medullary thyroid gland carcinoma: Of the 45 (37.2%) patients with known RET-mutant MTC, 25 (55.6%) had RET mutations first identified before advanced MTC diagnosis, and 20 (44.4%) had them first identified after advanced MTC diagnosis.